Aging Impairs Reverse Remodeling and Recovery of Ventricular Function after Isoproterenol-Induced Cardiomyopathy

dc.contributor.authorYáñez Bisbe, Laia
dc.contributor.authorGarcia Elias, Anna
dc.contributor.authorTajes Orduña, Marta
dc.contributor.authorAlmendros López, Isaac
dc.contributor.authorRodríguez Sinovas, Antonio
dc.contributor.authorInserte, Javier
dc.contributor.authorRuiz Meana, Marisol
dc.contributor.authorFarré Ventura, Ramon
dc.contributor.authorFarré, Núria
dc.contributor.authorBenito, Begoña
dc.date.accessioned2022-02-24T10:34:27Z
dc.date.available2022-02-24T10:34:27Z
dc.date.issued2021-12-01
dc.date.updated2022-02-24T10:34:27Z
dc.description.abstractAbstract: Information about heart failure with reduced ejection fraction (HFrEF) in women and the potential effects of aging in the female heart is scarce. We investigated the vulnerability to develop HFrEF in female elderly mice compared to young animals, as well as potential differences in reverse remodeling. First, HF was induced by isoproterenol infusion (30 mg/kg/day, 28 days) in young (10-week-old) and elderly (22-month-old) female mice. In a second set of animals, mice underwent isoproterenol infusion followed by no treatment during 28 additional days. Cardiac remodeling was assessed by echocardiography, histology and gene expression of collagen-I and collagen-III. Following isoproterenol infusion, elderly mice developed similar HFrEF features compared to young animals, except for greater cell hypertrophy and tissue fibrosis. After beta-adrenergic withdrawal, young female mice experienced complete reversal of the HFrEF phenotype. Conversely, reversed remodeling was impaired in elderly animals, with no significant recovery of LV ejection fraction, cardiomyocyte hypertrophy and collagen deposition. In conclusion, chronic isoproterenol infusion is a valid HF model for elderly and young female mice and induces a similar HF phenotype in both. Elderly animals, unlike young, show impaired reverse remodeling, with persistent tissue fibrosis and cardiac dysfunction even after beta-adrenergic withdrawal.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec718871
dc.identifier.idimarina9295575
dc.identifier.issn1661-6596
dc.identifier.urihttps://hdl.handle.net/2445/183447
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms23010174
dc.relation.ispartofInternational Journal of Molecular Sciences, 2021, vol. 23, num. 1, p. 174
dc.relation.urihttps://doi.org/10.3390/ijms23010174
dc.rightscc-by (c) Yáñez Bisbe, Laia et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationInsuficiència cardíaca
dc.subject.classificationEnvelliment
dc.subject.classificationMalalties del cor
dc.subject.otherHeart failure
dc.subject.otherAging
dc.subject.otherHeart diseases
dc.titleAging Impairs Reverse Remodeling and Recovery of Ventricular Function after Isoproterenol-Induced Cardiomyopathy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
718871.pdf
Mida:
2.24 MB
Format:
Adobe Portable Document Format